A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction

Clinical trial NCT05891613 · COMPLETED

Trial details

NCT number: NCT05891613
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Reduction

Start date: 2024-01-24
Primary completion: 2025-10-06
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.